Government ContextGovernment Context
DocumentsDocuments by topicDocuments by agencyPricingLog inCreate account
Nonrulemaking

Requests that the FDA determine and declare that Dexchlorpheniramine Maleate Tablets 1 mg is suitable for submission in an Abbreviated New Drug Application (ANDA)

🏛 Food and Drug Administration (FDA)FDA-2026-P-7181
Documents
7
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 7Supporting & Related Material 5Other 2
📄 Primary document
OtherJun 29, 2026
Suitability Petition from Senores Pharmaceuticals, Inc.
No comment period
Open →